Continuing Access to In-Home IVIG Act
USA116th CongressHR-7839| House
| Updated: 7/29/2020
Doris O. Matsui
Democratic Representative
California
Cosponsors (13)
David Schweikert (Republican)Adrian Smith (Republican)Tom Cole (Republican)Robin L. Kelly (Democratic)Ed Case (Democratic)Sheila Jackson Lee (Democratic)Derek Kilmer (Democratic)Kevin Brady (Republican)Brad R. Wenstrup (Republican)G. K. Butterfield (Democratic)Josh Harder (Democratic)George Holding (Republican)Grace F. Napolitano (Democratic)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Continuing Access to In-Home IVIG Act This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
Congressional oversightDrug therapyGovernment studies and investigationsHealth programs administration and fundingHealth technology, devices, suppliesHereditary and development disordersHome and outpatient careImmunology and vaccinationMedicare
Continuing Access to In-Home IVIG Act
USA116th CongressHR-7839| House
| Updated: 7/29/2020
Continuing Access to In-Home IVIG Act This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Doris O. Matsui
Democratic Representative
California
Cosponsors (13)
David Schweikert (Republican)Adrian Smith (Republican)Tom Cole (Republican)Robin L. Kelly (Democratic)Ed Case (Democratic)Sheila Jackson Lee (Democratic)Derek Kilmer (Democratic)Kevin Brady (Republican)Brad R. Wenstrup (Republican)G. K. Butterfield (Democratic)Josh Harder (Democratic)George Holding (Republican)Grace F. Napolitano (Democratic)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional oversightDrug therapyGovernment studies and investigationsHealth programs administration and fundingHealth technology, devices, suppliesHereditary and development disordersHome and outpatient careImmunology and vaccinationMedicare